<p>Survival of UM patients were estimated according to HMGA1 expression levels and Ki67 LI. Significant differences in disease-free survival rates were observed (<b>A, B</b>). Significant differences in disease-specific survival rates were also observed (<b>C, D</b>). P values were calculated with a log-rank test.</p
<p>Kaplan-Meier survival curves for 30-day survival according to the cutoff (>2.6 mmol/L) in all pat...
<p>(A) Overall survival and (B) progression-free survival according to baseline serum miR-21 levels ...
<p>Survival rates were calculated by the Kaplan-Meier test and compared by log-rank test. (solid lin...
(a) Progression-free survival and (b) overall survival for patients with more than 70% reduction in ...
<p>HYAL1. Strong expressions of HA (P=0.008) and HAS2 (p=0.022) and weak expression of HYAL1 (p=0.00...
<p>Kaplan-Meier survival curves for overall survival and disease progression-free rate.</p
<p>OS in 222 patients (A). OS in the overall population and by MICA expression (B). OS in the overal...
<p>Survival analyses were performed using Kaplan-Meier curves and log-rank tests to detect differenc...
Kaplan-Meier curve of overall survival based on TG-Peak at baseline (tertiles), for all patients and...
A: Kaplan-Meier survival curve for major adverse cardiovascular events (MACE: cardiovascular death, ...
<p>Kaplan-Meier curves showing overall survival (A) and progression free survival (B) with 95% confi...
<p>Kaplan-Meier curve for overall survival regarding UA level <5.1 mg/dl versus UA level ≥5.1 mg/dl ...
<p>Kaplan-Meier survival curve estimates showing the effect of baseline IGF-1R expression (left) and...
<p>Kaplan-Meier survival curves showing a poorer prognosis of patients with symptoms compared to tho...
<p>Kaplan-Meier survival curves for different treatment protocols and biomarker as well as the impac...
<p>Kaplan-Meier survival curves for 30-day survival according to the cutoff (>2.6 mmol/L) in all pat...
<p>(A) Overall survival and (B) progression-free survival according to baseline serum miR-21 levels ...
<p>Survival rates were calculated by the Kaplan-Meier test and compared by log-rank test. (solid lin...
(a) Progression-free survival and (b) overall survival for patients with more than 70% reduction in ...
<p>HYAL1. Strong expressions of HA (P=0.008) and HAS2 (p=0.022) and weak expression of HYAL1 (p=0.00...
<p>Kaplan-Meier survival curves for overall survival and disease progression-free rate.</p
<p>OS in 222 patients (A). OS in the overall population and by MICA expression (B). OS in the overal...
<p>Survival analyses were performed using Kaplan-Meier curves and log-rank tests to detect differenc...
Kaplan-Meier curve of overall survival based on TG-Peak at baseline (tertiles), for all patients and...
A: Kaplan-Meier survival curve for major adverse cardiovascular events (MACE: cardiovascular death, ...
<p>Kaplan-Meier curves showing overall survival (A) and progression free survival (B) with 95% confi...
<p>Kaplan-Meier curve for overall survival regarding UA level <5.1 mg/dl versus UA level ≥5.1 mg/dl ...
<p>Kaplan-Meier survival curve estimates showing the effect of baseline IGF-1R expression (left) and...
<p>Kaplan-Meier survival curves showing a poorer prognosis of patients with symptoms compared to tho...
<p>Kaplan-Meier survival curves for different treatment protocols and biomarker as well as the impac...
<p>Kaplan-Meier survival curves for 30-day survival according to the cutoff (>2.6 mmol/L) in all pat...
<p>(A) Overall survival and (B) progression-free survival according to baseline serum miR-21 levels ...
<p>Survival rates were calculated by the Kaplan-Meier test and compared by log-rank test. (solid lin...